Navigation Links
Start Licensing, Inc. Welcomes FDA's Finding of Safety of Food From Cloned Animals
Date:1/16/2008

AUSTIN, Texas, Jan. 16 /PRNewswire-USNewswire/ -- Start Licensing, Inc. ("Start"), a joint venture of Geron Corporation (Nasdaq:) and Exeter Life Sciences supports the final risk assessment released by the US Food and Drug Administration on January 15. The assessment concluded that meat and dairy products from animal clones and their offspring are safe for human consumption.

"FDA's conclusion is consistent with a report released January 11, 2008 by the European Food Safety Authority and studies in other countries. These findings open the door to widespread adoption of the technology platform to enhance the quality of meat and dairy products" said Jonathan Thatcher, president of Start. "With this safety conclusion, ranchers and livestock producers can look to cloning technology to rapidly increase the best genetics, including quality and health traits, in their herds."

Created in 2005, Start is a joint venture of Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. Start manages and licenses a worldwide portfolio of intellectual property rights related to animal reproductive technologies, including foundational nuclear transfer cloning technology developed at the Roslin Institute. The nuclear transfer patents managed by Start have been upheld by the US PTO in three separate patent interference proceedings and in opposition proceedings by patent offices in other countries. Start's licensees are engaged in research and product development in food production, medical applications and other fields.

For more information call Natalie Garrett, Start Licensing/Turner Strategies, 202-466-9633


'/>"/>
SOURCE Start Licensing, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
2. Visiprise Manufacturing Wins START-IT Top 50 Technologies Award
3. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
4. Optherion, Inc. Completes $37 Million Start Up Financing
5. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
8. SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder
9. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
10. Industry Executives Finding Value in Shift of Scientific Publications
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):